Kalaris Therapeutics, Inc.
KLRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001754068
No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Kalaris Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- −11 vs. Q2 2024
- Shares held
- 44.9M
- −1.32M (−2.9%) vs. Q2 2024
- Total value
- $36.3M
- +$2.87M (+8.6%) vs. Q2 2024
- New holders
- 3
- 5 more added
- Sold out
- 14
- 30 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KLRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $73.4M |
| Q1 2026 | 58 | $107.2M |
| Q4 2025 | 51 | $151.9M |
| Q3 2025 | 32 | $76.4M |
| Q2 2025 | 30 | $35.7M |
| Q1 2025 | 32 | $111.4M |
| Q4 2024 | 53 | $20.7M |
| Q3 2024 | 60 | $36.3M |
| Q2 2024 | 72 | $33.9M |
| Q1 2024 | 77 | $36.4M |
| Q4 2023 | 82 | $28.5M |
| Q3 2023 | 90 | $115.5M |
| Q2 2023 | 94 | $183.6M |
| Q1 2023 | 89 | $156.0M |
| Q4 2022 | 86 | $193.1M |
| Q3 2022 | 87 | $293.7M |
| Q2 2022 | 84 | $109.6M |
| Q1 2022 | 84 | $184.1M |
| Q4 2021 | 84 | $329.4M |
| Q3 2021 | 80 | $640.3M |
| Q2 2021 | 84 | $521.8M |
| Q1 2021 | 75 | $624.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Kalaris Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 11,294,585 | $9.13M | 0.31% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 11,202,000 | $9.06M | 1.45% | +1,402,000+14.3% | Added |
| Siren, L.L.C. | 6,597,167 | $5.33M | 0.27% | +6,597,167 | New |
| Millennium Management LLC | 3,284,800 | $2.66M | 0.00% | −10,929−0.3% | Reduced |
| Vanguard Group Inc | 2,647,010 | $2.14M | 0.00% | 00.0% | Unchanged |
| Redmile Group, LLC | 1,907,969 | $1.54M | 0.09% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 1,069,696 | $864.8K | 0.39% | +84,863+8.6% | Added |
| Renaissance Technologies LLC | 776,857 | $628.1K | 0.00% | −14,343−1.8% | Reduced |
| BlackRock, Inc. | 632,890 | $511.7K | 0.00% | +632,890 | New |
| BML Capital Management, LLC | 603,086 | $487.6K | 0.29% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 585,548 | $473.5K | 0.00% | −61,929−9.6% | Reduced |
| Two Sigma Advisers, LP | 508,300 | $411.0K | 0.00% | −125,700−19.8% | Reduced |
| RBF Capital, LLC | 449,014 | $363.0K | 0.02% | 00.0% | Unchanged |
| Marshall Wace, LLP | 324,658 | $263.0K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 310,604 | $251.1K | 0.00% | +1,744+0.6% | Added |
| D. E. Shaw & Co., Inc. | 296,461 | $239.7K | 0.00% | −179,124−37.7% | Reduced |
| Two Sigma Investments, LP | 295,161 | $238.6K | 0.00% | −56,814−16.1% | Reduced |
| Acadian Asset Management LLC | 224,343 | $181.0K | 0.00% | −951,611−80.9% | Reduced |
| State Street Corp | 222,439 | $179.8K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 201,000 | $163.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 178,883 | $144.6K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 158,418 | $128.1K | 0.00% | −278,913−63.8% | Reduced |
| Goldman Sachs Group Inc | 93,308 | $75.4K | 0.00% | −194,682−67.6% | Reduced |
| Price T Rowe Associates Inc | 85,900 | $70.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 84,200 | $68.1K | 0.00% | −23,078−21.5% | Reduced |
| Jane Street Group, LLC | 83,351 | $67.4K | 0.00% | −89,680−51.8% | Reduced |
| Samsara BioCapital, LLC | 82,336 | $66.6K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 69,769 | $56.3K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 60,500 | $48.9K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 57,055 | $46.1K | 0.00% | −287,507−83.4% | Reduced |
| Tudor Investment Corp Et Al | 49,620 | $40.1K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 47,380 | $38.3K | 0.00% | −22,572−32.3% | Reduced |
| Amundi | 45,448 | $36.0K | 0.00% | +45,448 | New |
| Lido Advisors, LLC | 39,322 | $31.8K | 0.00% | −40,094−50.5% | Reduced |
| Qube Research & Technologies Ltd | 34,341 | $27.8K | 0.00% | −44,471−56.4% | Reduced |
| Point72 Asia (Singapore) Pte. Ltd. | 30,261 | $24.5K | 0.00% | −46,017−60.3% | Reduced |
| Susquehanna International Group, LLP | 27,213 | $22.0K | 0.00% | −140,893−83.8% | Reduced |
| XTX Topco Ltd | 26,523 | $21.4K | 0.00% | −20,710−43.8% | Reduced |
| Bank of America Corp | 24,118 | $19.5K | 0.00% | +1,790+8.0% | Added |
| AQR Capital Management LLC | 20,843 | $16.9K | 0.00% | −64,925−75.7% | Reduced |
| Cubist Systematic Strategies, LLC | 19,997 | $16.2K | 0.00% | −29,819−59.9% | Reduced |
| Advisor Group Holdings, Inc. | 18,700 | $15.1K | 0.00% | +3,700+24.7% | Added |
| PFG Investments, LLC | 16,000 | $12.9K | 0.00% | −3,000−15.8% | Reduced |
| JustInvest LLC | 14,331 | $11.6K | 0.00% | −7,879−35.5% | Reduced |
| Point72 (DIFC) Ltd | 14,200 | $11.5K | 0.00% | −3,027−17.6% | Reduced |
| Federated Hermes, Inc. | 13,214 | $10.7K | 0.00% | −2,016−13.2% | Reduced |
| Catalyst Funds Management Pty Ltd | 13,000 | $10.5K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 10,478 | $8.47K | 0.00% | −5,636−35.0% | Reduced |
| Strengthening Families & Communities, LLC | 6,200 | $5.01K | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 3,000 | $2.43K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,319 | $1.88K | 0.00% | −18,239−88.7% | Reduced |
| UBS Group AG | 2,222 | $1.80K | 0.00% | −35,059−94.0% | Reduced |
| JPMorgan Chase & Co | 2,178 | $1.76K | 0.00% | −4,584−67.8% | Reduced |
| CWM, LLC | 1,004 | $1.00K | 0.00% | −1,271−55.9% | Reduced |
| Parallel Advisors, LLC | 1,145 | $926 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 990 | $800 | 0.00% | −6,655−87.1% | Reduced |
| Farther Finance Advisors, LLC | 862 | $697 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 695 | $562 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 451 | $365 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 8 | $6 | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 0 | $0 | 0.00% | −6,597,167−100.0% | Sold out |
| Pennant Investors, LP | 0 | $0 | 0.00% | −215,700−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −194,473−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −137,897−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −51,224−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −31,765−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −26,032−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −18,494−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −15,947−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −14,565−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −9,294−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −2,561−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −467−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −683−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |